openPR Logo
Press release

Gastric Ulcers Market Growing at a CAGR of around 4.3%

12-11-2025 01:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Gastric Ulcers Market

Gastric Ulcers Market

Gastric Ulcers Market Overview

The Gastric Ulcers Market was valued at ~USD 6.4 billion in 2024 and is projected to reach ~USD 9.8 billion by 2034, growing at a CAGR of around 4.3%. Growth is driven by increasing prevalence of H. pylori infections, widespread use of NSAIDs, rising stress-related gastrointestinal disorders, and greater demand for advanced acid-suppressing therapies.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71140

Key Market Drivers
• Increasing cases of Helicobacter pylori infection globally.
• High usage of NSAIDs, leading to drug-induced gastric ulcers.
• Growing elderly population with higher susceptibility to GI disorders.
• Rising adoption of PPIs, H2 receptor antagonists, and combination therapies.
• Improved diagnostic capabilities including endoscopy and stool antigen testing.

Challenges
• Long-term side effects associated with chronic PPI use.
• Growing resistance to H. pylori antibiotic treatments.
• Underdiagnosis in low-income regions due to limited endoscopy access.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71140/gastric-ulcers-market

Market Segmentation
By Drug Class
• Proton pump inhibitors (PPIs)
• H2 receptor antagonists
• Antacids
• Cytoprotective agents
• Antibiotic combinations (H. pylori eradication)

By Disease Type
• H. pylori-associated gastric ulcers
• NSAID-induced ulcers
• Stress-related ulcers
• Refractory/complicated ulcers

By Diagnosis
• Endoscopy
• Urea breath test
• Stool antigen test
• Blood/serological tests

By End User
• Hospitals
• Gastroenterology specialty clinics
• Diagnostic centers
• Homecare (prescription-based therapy)

By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71140

Regional Insights
• North America dominates due to strong diagnosis rates and high adoption of PPIs and H2 blockers.
• Europe benefits from structured ulcer management and widespread H. pylori testing.
• Asia-Pacific shows the fastest growth due to high H. pylori prevalence and rising healthcare investment.

Key Companies
Pfizer, Takeda, AstraZeneca, Bayer, GSK, Sanofi, Abbott, Novartis, Johnson & Johnson, and Dr. Reddy's Laboratories.

Future Outlook
The market is expected to expand steadily with the development of next-generation PPIs, rising antibiotic-resistance mitigation strategies, broader availability of non-invasive tests, and increased emphasis on patient-specific ulcer management.

This report is also available in the following languages : Japanese (胃潰瘍市場), Korean (위궤양 시장), Chinese (胃溃疡市场), French (Marché des ulcères gastriques), German (Markt für Magengeschwüre), and Italian (Mercato delle ulcere gastriche), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71140

Our More Reports:

Post Operative Pain Management Market
https://exactitudeconsultancy.com/reports/70987/post-operative-pain-management-market

Endometriosis Patient Pool Market
https://exactitudeconsultancy.com/reports/70745/endometriosis-patient-pool-market

Chronic Rhinosinusitis without Nasal Polyps Market
https://exactitudeconsultancy.com/reports/70758/chronic-rhinosinusitis-without-nasal-polyps-market

Nasal Polyposis Market
https://exactitudeconsultancy.com/reports/70749/nasal-polyposis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Ulcers Market Growing at a CAGR of around 4.3% here

News-ID: 4311758 • Views:

More Releases from Exactitude Consultancy

Fibrinogen Concentrate Market is projected to reach USD 6.28 billion by 2034
Fibrinogen Concentrate Market is projected to reach USD 6.28 billion by 2034
The global Fibrinogen Concentrate Market was valued at USD 3.12 billion in 2024 and is projected to reach USD 6.28 billion by 2034, growing at a CAGR of 7.2% during 2025-2034. Increasing incidence of trauma cases, rising volume of major surgeries, growing awareness of congenital fibrinogen deficiency, and expanded utilization of fibrinogen replacement therapy in cardiac and obstetric bleeding are key factors fueling market growth. Download Full PDF Sample Copy of
Exocrine Pancreatic Insufficiency (EPI) Market CAGR of around 5.9%
Exocrine Pancreatic Insufficiency (EPI) Market CAGR of around 5.9%
Exocrine Pancreatic Insufficiency (EPI) Market The Exocrine Pancreatic Insufficiency (EPI) Market was valued at USD 3.4 billion in 2024 and is projected to reach USD 5.8 billion by 2034, growing at a CAGR of around 5.9%. Growth is driven by increasing prevalence of chronic pancreatitis, cystic fibrosis, and other digestive disorders, along with rising demand for pancreatic enzyme replacement therapies (PERT). Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/71138 Key Market
Eosinophilic Gastroenteritis Market is valued at around USD 160 million in 2024 and is projected to reach approximately USD 290 million by 2034
Eosinophilic Gastroenteritis Market is valued at around USD 160 million in 2024 …
Eosinophilic Gastroenteritis Market The Eosinophilic Gastroenteritis (EGE) Market is valued at around USD 160 million in 2024 and is projected to reach approximately USD 290 million by 2034, registering a CAGR of about 6.1%. Growth is supported by increasing diagnosis rates, expanding awareness of eosinophilic gastrointestinal disorders, and improved imaging and biopsy-based testing. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/71136 Key Market Drivers • Increasing incidence of allergic and immune-mediated gastrointestinal conditions. • Greater
Body Contouring Devices Market is projected to reach USD 16.04 billion by 2034
Body Contouring Devices Market is projected to reach USD 16.04 billion by 2034
The global Body Contouring Devices Market was valued at USD 7.28 billion in 2024 and is projected to reach USD 16.04 billion by 2034, growing at a CAGR of 8.3% during 2025-2034. Growth is driven by rising demand for minimally invasive cosmetic procedures, growing global obesity rates, increasing aesthetic awareness, and expanding medical spa and dermatology clinic networks. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70968 Body contouring devices are

All 5 Releases


More Releases for Gastric

Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Cancer Drugs Market Size By 2025? In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Ulcers Market Size By 2025? In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market? The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market? The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Gastric Cancer
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market. Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126 The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the